T
Tenax Therapeutics, Inc.TENX
Tenax Therapeutics, Inc. is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies. The Company owns global rights to develop and commercialize levosimendan, which it is developing for the treatment of PH-HFpEF, the most prevalent form of pulmonary hypertension globally, for which no product has been approved to.
US StocksHealthcareSmall CapBiotechnologyGrowth Stocks
TENX Price Trend
Tenax Therapeutics, Inc. · Full TradingView Chart
NASDAQ:TENX